Cleerly LABS vs Eko Murmur Analysis Software (EMAS)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS

AI Verdict

These tools are adjacent in their application within cardiology, addressing different aspects of heart health. Cleerly LABS focuses on comprehensive analysis of coronary CT angiography to detect and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. In contrast, Eko Murmur Analysis Software (EMAS) integrates with digital stethoscopes to detect and differentiate heart murmurs, providing clinical decision support for early detection of valvular or structural heart disease.

Choose Cleerly LABS if…

Choose Cleerly LABS if you require a detailed, non-invasive assessment of coronary artery disease beyond traditional risk factors. This AI-powered tool is ideal for quantifying plaque burden, characterizing plaque types, and precisely measuring stenosis from CCTA scans to guide personalized treatment strategies and monitor disease progression over time.

View Cleerly LABS →

Choose Eko Murmur Analysis Software (EMAS) if…

Choose Eko Murmur Analysis Software (EMAS) if you need an AI-powered aid for rapid, point-of-care detection and differentiation of heart murmurs. It is best suited for clinicians seeking to enhance auscultation accuracy during physical exams, particularly in primary care or pediatric settings, to support early identification of structural heart disease.

View Eko Murmur Analysis Software (EMAS) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS Eko Murmur Analysis Software (EMAS)
Pricing Varies Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales.
Deployment Cloud, On-premise Cloud-based, Mobile App
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS), with its mobile application and integration with digital stethoscopes, offers a more accessible and intuitive point-of-care experience for a wider range of clinicians. Cleerly LABS, while web-based, is designed for complex CCTA analysis by specialists, suggesting a steeper learning curve and more specialized workflow.

Clinical Value

Cleerly LABS

Cleerly LABS provides a more comprehensive and quantitative assessment of coronary artery disease, including plaque characterization and disease progression tracking, which can significantly impact personalized heart disease management. While EMAS offers valuable early murmur detection, Cleerly's detailed insights into the underlying pathology of atherosclerosis represent a deeper level of clinical utility for established disease.

Pricing & Value

Eko Murmur Analysis Software (EMAS)

EMAS offers a free basic AI analysis for murmur detection, making it highly accessible for initial screening and widespread adoption. Cleerly LABS, with its high per-analysis cost and potential for significant out-of-pocket expenses, represents a more premium and less accessible pricing model.

Enterprise Readiness

Cleerly LABS

Cleerly LABS explicitly mentions robust integration capabilities with PACS, RIS, and EHR systems via its Cleerly Proxy, indicating a strong fit for existing enterprise imaging workflows. While EMAS is also cloud-based, FDA-cleared, and HIPAA compliant with EHR-compatible reports, its mobile-first deployment might require different enterprise IT considerations compared to a dedicated web-based imaging platform.

Innovation

Cleerly LABS

Cleerly LABS demonstrates a higher degree of innovation by leveraging AI for comprehensive, quantitative characterization of coronary plaque and ischemia from CCTA, moving beyond traditional stenosis assessment to redefine cardiovascular risk stratification. While EMAS innovates by bringing AI-powered auscultation to the point of care, Cleerly's approach addresses a more complex diagnostic challenge with potentially broader implications for disease management.

Support & Docs

Eko Murmur Analysis Software (EMAS)

Eko offers a more diverse and accessible range of support options, including phone, chat, live Q&A sessions, and scheduled calls, in addition to extensive online documentation and user manuals. Cleerly provides client support via a form and during business hours, but Eko's broader interactive support channels offer a more comprehensive user experience.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS Eko Murmur Analysis Software (EMAS)
Tool Name Cleerly LABS Eko Murmur Analysis Software (EMAS)
Company Cleerly Eko Devices
Primary Function AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease.
Key Modalities Analyzed Coronary CT angiography (CCTA) Heart sound (PCG) and optional ECG data
Target Specialties Cardiology, Radiology Cardiology, Internal Medicine, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and Eko Murmur Analysis Software (EMAS).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is an AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. Eko Murmur Analysis Software (EMAS) is an FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease.
Cleerly LABS requires coronary CT angiography (CCTA) images for analysis and integrates with PACS, RIS, and EHR systems via an on-site Cleerly Proxy. Eko Murmur Analysis Software (EMAS) analyzes heart sound (PCG) and optional ECG data captured by Eko digital stethoscopes, accessed via a mobile application, and can generate EHR-compatible PDF reports.
Cleerly LABS is priced per analysis, with a retail price of $1500, currently offered at $750, not including the separate CCTA scan cost, often resulting in $1000-$1500 total out-of-pocket. Eko Murmur Analysis Software offers basic AI analysis for murmur detection for free with the Eko App, while paid subscriptions (Eko+) are required for full features like AFib detection, recording, saving, and sharing reports, and a separate telehealth subscription is needed for live streaming.
Cleerly LABS is primarily for Cardiology and Radiology specialties, focusing on adults for personalized heart disease risk assessment and tracking disease progression. Eko Murmur Analysis Software (EMAS) serves Cardiology, Internal Medicine, and Pediatrics, assisting in the early detection of heart and lung disease in both adult and pediatric patients.
Cleerly LABS provides comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with an additional module), 3D visualization, and personalized heart disease risk assessment. Eko Murmur Analysis Software (EMAS) provides FDA-cleared AI for murmur detection, differentiates innocent and structural heart murmurs, and offers clinical decision support based on analyzed heart sound and optional ECG data.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.